1. Home
  2. NTRA vs CMS Comparison

NTRA vs CMS Comparison

Compare NTRA & CMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • CMS
  • Stock Information
  • Founded
  • NTRA 2003
  • CMS 1987
  • Country
  • NTRA United States
  • CMS United States
  • Employees
  • NTRA N/A
  • CMS N/A
  • Industry
  • NTRA Medical Specialities
  • CMS Power Generation
  • Sector
  • NTRA Health Care
  • CMS Utilities
  • Exchange
  • NTRA Nasdaq
  • CMS Nasdaq
  • Market Cap
  • NTRA 24.9B
  • CMS 21.5B
  • IPO Year
  • NTRA 2015
  • CMS N/A
  • Fundamental
  • Price
  • NTRA $173.27
  • CMS $73.61
  • Analyst Decision
  • NTRA Strong Buy
  • CMS Buy
  • Analyst Count
  • NTRA 17
  • CMS 12
  • Target Price
  • NTRA $192.41
  • CMS $76.82
  • AVG Volume (30 Days)
  • NTRA 1.1M
  • CMS 2.4M
  • Earning Date
  • NTRA 11-11-2025
  • CMS 10-30-2025
  • Dividend Yield
  • NTRA N/A
  • CMS 2.96%
  • EPS Growth
  • NTRA N/A
  • CMS 3.96
  • EPS
  • NTRA N/A
  • CMS 3.39
  • Revenue
  • NTRA $1,964,250,000.00
  • CMS $8,017,000,000.00
  • Revenue This Year
  • NTRA $24.28
  • CMS $8.73
  • Revenue Next Year
  • NTRA $15.22
  • CMS $3.99
  • P/E Ratio
  • NTRA N/A
  • CMS $21.60
  • Revenue Growth
  • NTRA 44.38
  • CMS 8.25
  • 52 Week Low
  • NTRA $117.27
  • CMS $63.97
  • 52 Week High
  • NTRA $183.00
  • CMS $76.45
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 59.76
  • CMS 61.10
  • Support Level
  • NTRA $157.43
  • CMS $72.99
  • Resistance Level
  • NTRA $173.62
  • CMS $74.56
  • Average True Range (ATR)
  • NTRA 5.35
  • CMS 1.14
  • MACD
  • NTRA 0.04
  • CMS 0.26
  • Stochastic Oscillator
  • NTRA 67.61
  • CMS 80.63

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About CMS CMS Energy Corporation

CMS Energy is an energy holding company with three principal businesses. Its regulated utility, Consumers Energy, provides regulated natural gas service to 1.8 million customers and electric service to 1.9 million customers in Michigan. NorthStar Clean Energy, formerly CMS Enterprises, is engaged in wholesale power generation, including contracted renewable energy. CMS sold EnerBank in October 2021.

Share on Social Networks: